載入...
Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition
Histologic transformation from non-small cell to small cell lung cancer has been reported as a resistance mechanism to targeted therapy in EGFR-mutant and ALK fusion-positive lung cancers. Whether small cell transformation occurs in other oncogene-driven lung cancers remains unknown. Here we analyze...
Na minha lista:
| 發表在: | NPJ Precis Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7400592/ https://ncbi.nlm.nih.gov/pubmed/32802958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41698-020-0127-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|